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1. Introduction 
Saliva is a complex fluid produced by the major and minor salivary glands and is a mixture 
of several constituents of non-salivary origin such as gingival crevicular fluid, expectorated 
bronchial and nasal secretions, serum and blood derivatives from oral wounds, 
microorganisms, desquamated epithelial cells, other cellular components and food debris 
(Kaufmann & Lamster, 2002). 
Saliva is considered a mirror of body health and is composed of variety of analytes from 
systemic sources that reach the oral cavity through various pathways. Because water is a 
major constituent, saliva plays a key role in the lubrication and repair of oral mucosa, 
formation and swallowing of food bolus, digestion of starch, facilitation of food tasting and 
control of oropharyngeal microbial population (Lawrence, 2002). 
Salivary constituents comprises both organic and inorganic components in generally small 
quantities that vary with changes in flow, yet continually providing an array of functions. 
The components, especially proteins are multifunctional, redundant, and amphifunctional 
as research into the complex roles of proteins and mucins support this theory. The 
multifarious components within the saliva not only protect the integrity of oral tissues, but 
also provide clues to various local and systemic conditions and diseases. These salivary 
components are constantly being explored as markers of various diseases and to monitor 
general health. Despite not being one of the popular bodily fluids as it is lacks the drama of 
blood, sincerity of sweat and emotional appeal of tears; a growing number of researchers 
from various fields including oncology are finding saliva as a useful diagnostic tool 
(Mandel, 1990). 
The role of saliva as a diagnostic tool has advanced exponentially over the past decade. The 
ability to measure a wide range of molecular components in saliva and compare them with 
serum coupled with the easy and non-invasive method of collection has made it feasible to 
study microbes, chemical and immunological markers. As a consequence these advances in 
technology have helped to move saliva beyond measuring oral health characteristics to 
where it may now be used to measure essential features of overall health (Streckfus & Bigler, 
2003) 
The scientific literature on using human saliva as a diagnostic tool began to emerge in 
1960’s. Early attempts at the usage of saliva as a diagnostic tool was confusing as the studies 
www.intechopen.com
 
Oral Cancer 
 
228 
were not precise and lacked uniformity. Over the years, identification of important 
constituents in the saliva, invention of more sensitive techniques for their detection aided 
with the description of various methods of saliva collection and the type of saliva to be 
collected, contributed in transforming saliva as a major diagnostic tool. 
A large number of diagnostic analytes have been shown to be present in saliva including 
steroid hormones and HIV antibody. The past few years have seen the development of 
salivary diagnostic tools to monitor various oral diseases ranging from periodontal diseases, 
dental caries to infections and autoimmune diseases. The challenge of salivary diagnostics is 
to discover its potential and optimizing engineering technologies for the use of this biofluid. 
The challenge of making salivary diagnostics a clinical reality is in establishing the scientific 
foundation and clinical validations needed to position it as a highly accurate and feasible 
technology that can achieve definite point of care assessment of health and diseases states 
(Wong, 2006). 
The various conditions where saliva has been used as a diagnostic tool includes 
autoimmune diseases like Sjogrens syndrome (Kalk et al., 2002; Tishler et al., 1997), head 
and neck cancer and cancer of other systemic sites, infectious diseases inclusive of viral, 
bacterial and fungal diseases, hereditary diseases like cystic fibrosis, drug and hormone 
monitoring and also for the diagnosis of systemic diseases like cardiovascular diseases, 
respiratory diseases, renal diseases and psychosomatic disorders. Of the lot, use of saliva as 
a diagnostic aid in oral cavity cancer is gaining immense popularity due to the close 
anatomic proximity of saliva to both pre-malignant and malignant neoplasms making it 
ideal for screening of these lesions.  
Oral squamous cell carcinoma (OSCC) is one of the most common epithelial malignancies 
with significance morbidity and mortality. Inspite of diagnostic and therapeutic advances 
over the decades, the disease still remains a challenge for medical professionals with the five 
year survival rate being 30%-50% (Li et al., 2004). Recent observations indicate that the 
clinical and histological appearance of oral mucosa may not truly depict the damage 
occurring at the genetic level. This phenotypic and genotypic disparity may account in part 
for the failure to establish effective screening and surveillance protocols based on traditional 
clinical and microscopic examination (Li et al., 2004). Carcinogenesis is multistep process 
involving initiation, promotion and progression and evidence indicates that these are driven 
by accumulation of specific gene alterations (Sun, 1990). An understanding of the molecular 
mechanisms involved in OSCC is helpful in providing a more complete picture of the ways 
in which tumor arise and advance and a rationale for novel strategies of cancer detection. 
The oral cavity is particularly conducive to such strategies, given the ease with which saliva 
and exfoliated cells can be collected (Westra & Califano, 2004). 
Tumor cells inhabit or produce biochemical substances referred to as tumor markers. These 
can be normal endogenous products that are produced at a greater rate in cancer cells or the 
products of newly switched on genes that remain quiescent in the normal cells (Malati, 
2007). Tumor marker may be present as intracellular substances in tissues or as released 
substances in circulating body fluids such as serum, urine, CSF, and saliva. Until recently, 
analysis for tumor markers were carried out in fluids other than saliva such as CSF, blood 
and urine. With recent diagnostic technological advances however, the role of saliva as a 
tool for diagnosis has advanced exponentially.  
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The source of information is largely derived from the variety of DNA’s, RNA’s and proteins 
present in the saliva. Salivary DNA represents the genetic information of the hosting human 
body, the oral microbiota and the infecting DNA-viruses. Salivary RNA provides 
information on the transcription rates of the host genes and those of oral microbiota. 
Salivary proteins represent genetic information and help to understand the translational 
regulation of the host body and the oral microbiota (Fabian et al., 2008). In addition, saliva is 
also useful in detection of other markers such as cell cycle markers (p16, p53 etc), growth 
factors (Epidermal growth factor, transforming growth factor etc), cell surface markers, 
oxidant and antioxidants among others.  
2. Properties of saliva 
Saliva is a complex hypotonic fluid composed of secretions from the major and the minor 
salivary glands. The major glands are the parotid, submandibular and sublingual glands 
which are located outside the oral cavity and the secretions are transported to the mouth 
through the duct system. The minor salivary glands are numerous and are scattered 
throughout the oral cavity. Saliva is formed in two stages, the formation of the primary 
saliva by acinar cells and intercalated ducts which is isotonic plasma like containing most of 
the organic components and all of the water secreted by salivary glands. The second stage 
involves the modification of the primary saliva by the removal or addition of various ions in 
the salivary ducts to produce a hypotonic fluid that enters the mouth (Turner & Sugiya, 
2002). 
A normal healthy adult produces 1-1.5liters/day of saliva composing of mixture of serous 
and mucinous material at a rate 0.5ml/min. Resting saliva is mainly composed of 
submandibular secretion while stimulated saliva is made of mainly parotid saliva. Each 
individual type of salivary gland secretes a characteristic type of saliva such as the secretion 
of serous saliva from parotid gland. 
Salivary output and composition depends on the activity of the autonomic nervous system 
through the sympathetic and parasympathetic systems. The parasympathetic supply is 
through the branch of facial nerve to sublingual and submandibular gland and a branch of 
IXn to the parotid gland. The sympathetic supply is through the fibers arising from first and 
the fourth thoracic segment and relaying in the superior sympathetic ganglion (Jenkins 
1978). Parasympathetic stimulation results in a high flow of saliva containing low levels of 
organic and inorganic compounds. Sympathetic stimulation produces a low volume of 
protein rich and potassium rich saliva (Chiappin et al, 2007). 
Saliva is composed of 99.5% water and 0.5% solid material which is inclusive of organic and 
inorganic constituents. The inorganic constituents are made of sodium, potassium, chlorine, 
bicarbonate, magnesium, calcium, phosphate, Thiocyanate, fluoride, lead, cadmium, copper, 
nitrite and nitrate. Sodium, potassium and chlorine contribute to the osmolarity of saliva 
and their concentration give diagnostic information related to the efficiency of ductal 
transport system. Bicarbonates are the most important buffer present in saliva resisting 
changes in salivary pH. Calcium, phosphate and fluoride have anti-caries activity. 
Thiocyanate acts as a anti-bacterial agent (Fergusson, 1994). Nitrate estimation in saliva 
provides a means of monitoring nitrate uptake and may also predict the future development 
of carcinoma. 
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The organic constituents are made up of proteins which include mucins and proline rich 
proteins which have lubricating properties, amylase and lipase with digestive properties, 
proteins such as sialoperoxidase, lysozyme (Thorn et al., 1989), lactoferrins, chitinase, 
cystatins, histatins, defensins, salivary leukocyte proteinase inhibitors, calprotectin, 
peroxidase, acid phosphatase, chromogranin A, sialin, agglutinin which have anti-microbial 
properties (Lamkin & Oppenheim, 1993). Other proteins include statherin, mucoproteins 
and glycoproteins. The rest of the organic constituents is made of blood  group substances, 
enzymes such as aldolase, β-glucoronidase, succinic dehydrogenase, kallikrein, hormones, 
cacrbohydrates, lipids, nitrogen containing compounds, vitamins, oral microorganisms, 
various gases like oxygen, nitrogen and carbon dioxide, growth factors like epidermal 
growth factor and cells of desquamated epithelium (Jenkins, 1978). 
The components present in the saliva could either be the inherent component of the saliva 
itself or the metabolites transferred from the plasma. The passage of plasma components 
into saliva involves several processes like, ultrafilteration through gap junctions between 
cells of secretory units, transudation of plasma compounds into oral cavity, from crevicular 
fluid or directly from oral mucosa and selective transport through cellular membranes by 
passive diffusion of lipophilic molecules or by active transport through protein channels 
(Chiappin et al., 2007). 
2.1 Collection and storage of saliva 
Saliva can be collected under both resting and stimulated conditions. The duration of the 
collecting period is important because flow rates vary with time. It is therefore important to 
standardize the collection procedure during the whole sampling period to keep the secretion 
rate as constant as possible. The methods of saliva collection comprise of collection of whole 
saliva and collection of glandular saliva. Among these, whole saliva collection is easiest and 
most feasible method. Specific glandular saliva can be collected with less easy methods. 
The common methods of resting-saliva collection include draining method, spitting method, 
suction method and swab method. Methods of stimulated saliva collection include 
masticatory and gustatory method. For collection of specific saliva, following methods can 
be used; a) for parotid saliva, saliva can be collected in a two-chambered type of suction and 
collection cup according to Lashley (Hu et al., 2004) and b) for submandibular saliva, saliva 
is collected by placing the tip of collection device at the orifice of the Wharton’s duct after 
occluding the parotid and sublingual ducts (Chiappin et al., 2007). 
Various oral fluid collector devices are currently available which aid in collection of 
unstimulated saliva. These include Orasure HIV 1, Uplink, Salivette, Toothette plus, BBL 
culture swabs, transorb wicks, oral diffusion sink and ultrafilterate saliva collector (Hansen 
et al., 2004). 
Saliva specimens after collection should preferably be kept on ice, aliquoted and frozen as 
soon as possible to maintain the sample integrity. The refrigeration prevents the 
degradation of some molecules in saliva and when necessary, bacterial growth may also be 
prevented (Chiappin et al., 2007). Storage procedure and time from the collection mainly 
affect the analysis of the biochemical variables characterized by temperature instability and 
bacterial growth. Some salivary compounds can have a very short half-life so that the 
sample to be analyzed needs a narrow range of time after collection, other substances can 
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remain stable for a longer time and may be detected and quantified after sometime (Nurkka 
et al., 2003). 
Certain approaches to store saliva in order to prevent degradation of salivary compounds 
include (Chiappan et al., 2007) 
 Immediate storage without any processing; if analysis is to be done within 30-90min, 
saliva can be stored at room temperature; for analysis after 3 to 6hrs from collection, 
storage is to be done at +40C and if analysis is to done after days to months after 
collection, storage is to be done at -200C or still better at -800C. 
 Snap freezing of saliva in liquid nitrogen 
 Inhibition of enzyme activity in saliva by mixing with certain enzyme inhibitors 
 Addition of sodium azide to retard bacterial growth  
 Addition of trifluor acetate to denature salivary enzymes that could degrade salivary 
compounds such as proteins and steroid hormones. 
For salivary DNA analysis, since the main source is from desquamated oral mucosal cells, 
pre-clearing of saliva before analysis is not recommended. In appropriate buffers of DNA 
extraction kits, saliva can be stored at room temperature for atleast one year. However 
before adding such buffer, saliva should be stored on ice to prevent microbial growth and to 
decrease salivary DNAase activity. Saliva can also be frozen and stored at -200C or -800C 
before extraction or after extraction before use (Fabian et al., 2008). 
For RNA analysis, saliva sample is usually centrifuged because the majority of RNAs in the 
centrifuged whole saliva are genuine human RNA’s (Park et al., 2007). For RNA studies 
focusing on oral microbiota, any kind of pre-clearing of saliva should be avoided. In order to 
avoid destruction of salivary RNA, the use of RNAase inhibitors are recommended. With 
the use of inhibitors, mRNA can be stabilized for longer run even in room temperature 
although cooling of saliva in ice is useful. RNA can be preserved in saliva by freezing at -
800C also (Fabian et al., 2008). 
For saliva protein analysis, centrifugation and/or microfiltration can be done. Pre-cleared 
saliva can be stored on ice without significant protein degradation for only few hours. 
Addition of protease inhibitors is advantageous especially for time consuming analysis 
procedures. Samples can be stored for few days at -200C. However prolonged storage at any 
temperature may lead to significant protein precipitation (Fabian et al., 2008). 
3. Technologies for saliva based diagnosis 
The complex nature of saliva consisting of mixture of various components makes it difficult 
to identify specific constituents. Recently, significant inroads have been made in discovery 
of a range of technologies which have high specificity and sensitivity in detection of salivary 
components. For assessment of the diagnostic technologies, a hierarchial model exist which 
consist of five basic levels of analysis at which the effectiveness of any diagnostic test should 
be evaluated. These include, analytic (precision and accuracy), diagnostic (sensitivity and 
specificity), patient outcome efficacy (medical decision making), operational (predictive 
value and efficiency) and cost / benefit (societal efficacy). This section discusses the various 
technologies available for saliva based diagnosis followed by the application aspect in oral 
cancer. 
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3.1 Proteomics 
The proteome represents the complete set of proteins encoded by genome and proteomics is 
the study of the proteome that investigates the cellular levels of all the isoforms and post-
translational modifications of proteins that are encoded by the genome of the cell under a 
given set of circumstances. Whilst a genome is more or less static, the protein levels in a cell 
can change dramatically as genes get turned on and off during the cells response to its 
environment. The proteomic analysis can ascertain function by either looking for changes in 
the expression of either all or subset of proteins, or by identifying binding partners for 
particular proteins and seeing how their interaction is affected by biological perturbation 
(Crocker & Murray, 2003). 
The proteomics in bodily fluids are valuable tool for diagnosis due to their high clinical 
potential as sources of disease markers. In principle a global analysis of the human salivary 
proteomes can provide a comprehensive spectrum of oral and general health. Furthermore, 
analysis of salivary proteomes over the course of complications may unveil morbidity 
signatures in the early stage and monitor disease progression (Lee & Wong, 2009). The total 
amount of protein in whole saliva ranges between 0.5-3mg/ml. This proteome consist of 
roughly 1000 protein sequences from which around 300 sequences are of human origin 
(Fabian et al., 2008). 
Proteomic analysis involves the following stages (Crocker & Murray, 2003): 
i. Separation of proteins: Before analyzing protein expression and abundance levels, 
proteins have to be isolated into a purified state. This is generally done by using two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE). To resolve the complex 
composition of saliva, 2D- PAGE, allows separation not only of different molecules of 
similar molecular weights, but also of different modification patterns or isoforms of the 
same protein (Lee & Wong, 2009). 
ii.  Analysis of comparative expression: Once separated, it is necessary to carry out some 
form of analysis to assess the relative abundance of the protein present. 
iii. Identification of protein species: Once a set of proteins showing differences in 
abundance between two or more states has been identified, mass spectrometric analysis 
is to be used to determine their identities. Proteins that are primarily identified by mass 
spectrometry (MS) can be further characterized by ionization methods such as 
electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI) 
(Lee & Wong, 2003). 
iv. Confirmatory experiments. 
Two main methods are used to resolve the protein mixture and then to visualize the 
individual components in such a way that their relative abundance can be quantified. The 
two methods are i) 2D gel electrophoresis followed by a variety of in-gel staining methods 
and ii) liquid chromatographic separation with subsequent UV &/or mass spectrometric 
detection. 
In 2D-PAGE, the proteins are initially separated by isoelectric focusing in the first dimension 
according to charge and then by SDS-PAGE in the second dimension according to size. This 
type of separation has the capacity to resolve complex protein mixtures, thus permitting 
analysis of hundreds of proteins at a time. For visualization, staining methods like 
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Coomassie staining, silver staining or Sypro post- electrophoretic fluorescent stains can be 
used. 
The non-gel based methods are used to overcome the problems associated with 2D-PAGE 
such as the difficulty in detecting low abundance proteins particularly integral membrane 
proteins. Two dimensional high performance liquid chromatography (2D-HPLC) is recently 
employed which uses a capillary HPLC column with a strong cation exchange matrix at the 
front end of the column which is followed by a reverse phase packing at the back end. Their 
approach involves the tryptic digestion of soluble and insoluble protein fractions of the 
entire yeast proteome, followed by the application of total tryptic peptides from the two 
fractions onto the strong cationic exchange matrix at the top of the column. A salt step 
gradient is then used to displace a fraction of the peptides onto the reverse phase packing. 
Displaced peptides are then eluted into the mass spectrometer using a solvent gradient 
which generates fragmented data that are used for automated searches against protein 
databases and identification. This procedure is than repeated in steps, each time using an 
increasing amount of salt to release further peptides from cation exchange to the reverse 
phase packing.  
Mass spectrometry is a powerful technique used for the identification of proteins from two 
dimensional cells. The ionization methods such as MALDI and ESI were developed by 
Karas & Hillenkomp (1988) and Fenn et al (1989) respectively. The combination of either of 
the above mass spectrometric techniques with the separation of proteins by 2D-PAGE is an 
established method of proteome analysis. In both the cases identification takes place at the 
peptide level and is therefore necessary to convert proteins in the excised gel pieces into 
peptides which can be extracted for analysis. Peptides can also be analyzed by MALDI to 
produce peptide mass fingerprints which are then matched against protein databases in 
order to identify corresponding proteins. It is also useful to identify which peptides in a 
tryptic digest have undergone post-translational modification like phosphorylation and 
glycosylation that are mediated by kinases and glycosyl transferases. An alternative mass 
spectrometric based method for protein identification is nanoelectrospray. This utilizes very 
fine glass capillaries with gold coated tips in order to produce a very fine spray which 
subsequently enables extremely low levels of protein digest mixtures to be analyzed at flow 
rated of approximately 20-50nl/min. 
3.2 Transcriptomics 
Salivary transcriptome diagnostics constitutes a novel clinical approach where a large panel 
of human RNAs can be readily detected in saliva. The large panel of human mRNA is 
determined by the use of microarray technology and after profiling, validation of 
transcriptome biomarkers will be done by quantitative real time PCR. Sometimes multiplex 
reverse transcriptase PCR are used to overcome problems with quantitative real time PCR 
(Lee & Wong, 2009). 
Microarray technologies have the advantage of simultaneously detecting and quantifying 
the expression of large number of genes health and disease. The technology involves the use 
of robotic automated miniaturized microscopic spots of aliquots of cDNAs or 
oligonucleotides from specific genes in a standardized high density gridded arrangement on 
glass (Muelker & Young, 2004). 
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The steps involved in microarray analysis consist of RNA extraction, sample labeling, 
hybridization and processing, image capture analysis and data analysis. RNA is first 
extracted from tissues or cells of interest. The quality of RNA extracted is paramount to the 
overall success of the microarray experiment as impurities in the sample can affect both the 
probe labeling efficiency and also stability of the fluorescent label. Further extraction of 
mRNA from the total RNA can be done resulting in a purer starting material (Crocker & 
Murray, 2003). 
The mRNA is transcribed in vitro with the concomitant inclusion of labeled nucleotides. The 
labels may be fluorescent or radioactive. After labeling, the cDNA is purified (to remove 
unincorporated nucleotides), mixed with a hybridization buffer and then applied to a cDNA 
microarray slide. The sample and the slide are heated prior to hybridization in order to 
separate double stranded DNA. A coverslip is applied or preferably a hybridization 
chamber is used to avoid evaporation and enable even hybridization. The hybridization and 
subsequent wash steps are carried out at a buffer stringency and temperature that enables 
hybridization of complementary strands of DNA but reduces non-specific binding. After 
hybridization, the microarray slides are scanned using either a laser or a phosphorimager. 
The images are analyzed using software that measures the intensity of the signal from the 
hybridized spotted genes which provide a measurement of the amount of cDNA bound. 
Thus, the initial concentration of mRNA is inferred. After the profiling of RNA by 
microarray, quantitative polymerase chain reaction is used to validate a subset of differently 
expressed transcripts that are identified by microarray analysis (Crocker & Murray, 2003). 
3.3 Polymerase chain reaction (PCR) 
PCR is a simple in-vitro method for amplification of specific short segments of DNA or 
cDNA reverse transcribed from RNA. The technique greatly simplifies genetic analysis and 
permits the study of all types of clinical samples. Oligonucleotide primers binding to the 
flanking regions of target sequence are used to initiate specific copying of DNA strands by 
DNA polymerase. The requirement for the reactions are template DNA to be studied, short 
single strand DNA primers, complementary to opposite strands of the flanking regions of 
the fragment of interest, the four nucleotide triphosphatases, a thermostable DNA 
polymerase and an appropriate buffer solution (Crocker & Murray, 2003). 
PCR involves three major steps which are denaturation at 94-960C for 30 seconds, annealing 
at 50-600C for 30 seconds and extension at 70-720C for one minute. The procedure begins 
with isolation of DNA from the sample. Heating separates complementary double stranded 
DNA into single strand forms intended to act as a template dictating nucleotide sequence in 
vitro. Two short oligonucleotides primers are designed to anneal to the template and flank 
the region of interest. A thermostable DNA polymerase known as Taq polymerase catalyzes 
the sequential addition of the four nucleotides to the primers. Cooling the solution permits 
the primers to bind to template DNA and then Taq polymerase catalyzes the addition of 
dNTPs to the template between the primers. Salt and buffers permit the Taq polymerase to 
catalyze the reaction. The reaction is repeated for around 35 to 40 cycles (Jordan et al., 2001). 
Reverse transcriptase-PCR (RT-PCR) is a modification of PCR which is important in 
transcriptomics as it permits analysis of mRNA and thus the study of gene transcription and 
easier analysis of multiple exons. RNA is extracted and mRNA reverse transcribed using 
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reverse transcriptase. The standard PCR is then carried out after generation of cDNA to 
amplify the desired region. Quantitative PCR (qPCR) is used for accurate quantification. The 
generated PCR products can be monitored during the reaction process using fluorescent 
labeled probes (Crocker & Murray, 2003). 
The visualization of amplification is done by agarose gel electrophoresis, southern blot, dot 
blot and reverse blot assays. The simplest method is agarose gel or polyacrylamide gel 
electrophoresis followed by ethidium bromide staining and viewing under UV illumination. 
The choice depends in the product size and the amount of resolution required (Crocker & 
Murray, 2003). 
3.4 Genomics 
Genomic analysis is one of the recent advances in the diagnosis of oral cancer and 
considerable research is being performed in this field. With the availability of high 
thoroughput technologies to harness genetic information from various sources like blood, 
saliva, etc., their usage has advanced exponentially. Stable cell free circulating DNA in 
plasma was first observed almost 60yrs ago. Plasma DNA were shown to exhibit tumor 
specific characteristics such as somatic mutations in tumor suppressor genes or oncogenes, 
microsatellite alterations, abnormal protein methylation, mitochondrial  DNA mutations 
and presence of tumor related viral RNA (Zimmermann et al., 2007). These DNA related 
changes were also found in saliva, the identification of which helps a great deal in diagnosis 
of oral cancer. The techniques that are available for detection of genetic changes are 
discussed below. 
3.4.1 Hybridization methods 
Hybridization refers to the pairing of complementary DNA or RNA strands to produce 
double stranded nucleic acids. This method uses a radio-labeled or fluorescence labeled 
DNA or RNA probe that binds to the target molecule of interest, permitting visualization. 
The target nucleic acids can either be immobilized in a membrane (blotting) or examined in 
tissue sections (in situ) (Jordan et al., 2001). 
Blotting technique involves the isolation of cell free mixture containing the biomolecules of 
interest, resolving the mixture into its component parts, transfer of the component parts 
onto a suitable membrane and detection of the biomolecules of interest. The blots are named 
according to the type of molecule that is blotted on the membrane i.e. DNA, RNA or protein 
as Southern, Northern and Western blotting respectively (Crocker & Murray, 2003). 
The southern blot technique is used to detect specific sequences within the mixture of DNA; 
this was first described by Southern in 1975. The DNA is size fractioned by gel 
electrophoresis and then transferred by capillary action to a membrane. The technique 
involves the transfer or blotting of DNA fragments onto a membrane. DNA is first 
enzymatically cleaved into smaller pieces by restricted endonucleases, then size separated 
by gel electrophoresis. After fragment separation, the DNA is transferred from the gel to 
nylon or nitrocellulose membrane through capillary action of a buffer as it is absorbed by 
blotting paper. Then the DNA is bound to the membrane by baking the membrane in a 
vacuum oven or by ultra-violet light cross linking. Finally specific DNA fragments can be 
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identified by hybridizing the membrane with labeled complementary DNA probes followed 
by detection of label by autoradiography or chemiluminescence (Jordan et al., 2001). 
The northern blot analysis is used for RNA detection wherein RNA as a target molecule are 
size separated by agar gel electrophoresis, transferred to nylon or nitrocellulose membrane 
and hybridized with specific probes (Jordan et al., 2001). However, precautions should be 
taken to prevent RNA degradation that can be caused by the presence of ribonucleases 
(Crocker & Murray, 2003). 
Western blotting detects antigenic determinants on protein molecules using polyclonal or 
monoclonal antibodies and often is described as immunoblotting. The first step involves 
solubilization of protein samples using sodium dodecyl sulphate and reducing agents like 
dithiothreitol or 2-mercaptoethanol. Individual proteins are then resolved by SDS 
polyacrylamide gel electrophoresis prior to electrophoretic transfer. Following blotting, 
conjugation with antibodies is performed and markers are visualized by autoradiography or 
chemiluminescence. The molecular weight of proteins is determined by comparison with a 
set of molecular weight markers which are co-electrophoresed (Crocker & Murray, 2003).  
3.4.2 Flow cytometry 
Flow cytometry is an important method used to analyze cell kinetics and protein expression 
in normal and tumor cells (Jordan et al., 2001). It is routinely used to measure DNA content 
of cells using dyes whose fluorescence is enhanced by binding to nucleic acids and 
accurately reflecting DNA content (Crocker & Murray, 2003). The dye most commonly used 
is propidium iodide. It can be excited by the blue line (488nm) of an argon ion laser, fitted 
into flow cytometers. When bound to double stranded nucleic acids, the dye fluoresces red. 
Other dyes that can be used are ethidium bromide, 7-aminoactinomycin, DRAQ5, Acridine 
orange etc. The labeled cells are then directed in a single file along a charged column 
through a laser beam which excites the fluorescent dye bound to the cell. The fluorescent 
emission from the excited cells are then collected by a fluorescence detector and analyzed. 
Cell size can also be detected by using data from the forward scatter of the excitation laser 
passing through the stream of single cells (Jordan et al., 2001). 
 
Diagrammatic representation of flow cytometric analysis  
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3.5 Point of care diagnostics 
In recent years, the concept and practice of Point of Care Testing (POCT) is gathering growing 
interests and remains an important discovery of the present century. POCT is advantageous 
over standard laboratory procedures by providing timely information to medical teams, 
facilitating rational, time critical decisions and has been demonstrated to improve patient 
outcomes in critical care settings. POCT facilitates personalized medicine allowing the 
caregiver to customize the therapy according to the patient needs. It reduces turnaround time 
for results which avoids the patients not following up with their caregiver after a test. POCT 
avoids some of the cost associated with sample handling, packaging, tracking and shipping to 
centralized labs and reduces the likelihood of samples being contaminated, mixed up, lost 
&/or degraded. POCT assays must be highly automated to minimize error, sample 
contamination and sample degradation. Early POCT were based on lateral flow (LF) assays. 
Recently microfluidics has been known to offer greater functionality and sophisticated flow 
control than lateral flow assays. The field is often referred to as micro-total analysis or lab on a 
chip (LOC). POCT microfludic devices are classified as instrumented or un-instrumented 
devices. Instrumented devices consist of a disposable cassette accompanied by a portable, 
durable analyzer. Un-instrumented devices are a reincarnation of the LF strips with added 
capabilities and sophistication. POCT can be used for detection of proteins and nucleic acids. 
For immunoassay test for small molecules and proteins, enzyme linked immunosorbent assay 
(ELISA) is the gold standard which shows high specificity and sensitivity. They utilize the 
high specificity of antibody binding to their target antigen ligand. The most ubiquitous point 
of care immunoassay is the LF strip also known as immunochromatographic strip. Another 
assay that is employed at point of care is based on microbeads. Microbeads with various 
functionalization are ubiquitous solid supports for capturing target molecules in both bench 
top and microfluidic system (Hart et al., 2011). 
In 1999, The NIDCR initiated a research workshop aimed at applications of microfluidics 
and micro/nanoelectromechanical system (MEMS/NEMS) to saliva based diagnostics. 
MEMS/NEMS is an integrated system that consists of a central unit for processing data and 
several other components that connect with the outside interface like microsensors. In 
continuation of development of saliva diagnostic technologies, in 2002, the NIDCR funded 
seven projects that explored different point of care systems to detect salivary analytes and 
provide an overall profile that correlated with a particular disease states. Electrochemical 
sensing, on chip PCR/RTPCR, microsphere based nano-biochip, microsphere based optical 
fiber assay, high thoroughput DNA microarray, surface plasmon resonance optical system 
and microchip electrophoretic immunoassay (Lee & Wong, 2009). 
Point of care microfluidic systems are being developed for diagnosis of oral and breast 
cancers. They permit concurrent detection of multiple salivary analytes including protein 
and nucleic acid. Oral fluid nanosensor test (OFNASET) is a handheld, automated, easy to 
use integrated system that will enable simultaneous and rapid detection of multiple salivary 
proteins and nucleic acids (Wong, 2006). 
4. Salivary tumor markers in oral cancer 
4.1 Protein markers 
Protein biomarkers in saliva are being analyzed both individually and as a panel of markers 
to aid in early detection of oral cancer and in implementing appropriate therapeutic regime. 
www.intechopen.com
 
Oral Cancer 
 
238 
Hu S et al (2008) tried to discover and validate differentially expressed proteins in saliva of 
oral squamous cell carcinoma (OSCC) patients which could serve as potential markers in its 
detection. The study was performed using subtractive proteomics approach to profile 
salivary proteins from oral cancer and matched healthy subjects followed by validation by 
immunoassay to identify a co-panel of candidate protein biomarkers for OSCC detection. 
461 and 438 non-redundant proteins were identified in OSCC and control groups 
respectively. Of these, 409 proteins were found in both the groups while the rest were 
specific for individual groups. Among the large number of proteins, many of them were 
differentially expressed as reflected by the differential number of mass spectrometric 
analysis. Proteins like MRP14 which is a calcium binding protein were significantly 
overexpressed in OSCC group. Polymeric immunoglobulin receptor (PIGR) was 
significantly downregulated in saliva of OSCC patients.  
The study showed up-regulation of 12 markers in OSCC group. Among these, 5 showed 
significant difference which included M2BP, MRP14, CD59, catalase and prolifin. Some 
proteins which were downregulated include clusterin (protein involved in apoptosis) that 
was absent in OSCC and present in control group. MRP14 expression which is also a 
calcium binding protein was found to be increased in OSCC group. MRP14 was show to 
have increased expression in another study performed in tongue cancer by He QY et al 
(2004). CD 59 (protectin) which was overexpressed in OSCC group enables the tumor cells 
to escape from complement dependent and antibody mediated killing (Ravindranath & 
Shuler, 2007). Profilin 1, another upregulated protein is a regulator of microfilament system 
and is involved in various signaling pathways via interaction with cytoplasmic and nuclear 
ligands. It may be secreted into tumor microenvironments during the early progressive 
stage of tumor formation. Catalase protects the cell against oxidative stress and altered 
levels of catalase are involved in carcinogenesis and tumor progression (Hu et al., 2008). 
 
Protein Functions 
M2BP Tumor antigen 
MRP14 Calcium binding protein 
CD 59 
Enables the tumor cells to escape from complement dependent and 
antibody mediated killing 
Prifilin 1 
Regulator of microfilament system and is involved in various 
signaling pathways 
Catalase Protects against oxidative stress 
Table 1. Overexpression of proteins in OSCC and their functional role. 
Analysis of salivary epithelial markers was performed in a study which included CA125, 
CA19-9, tissue polypeptide antigen (TPA), carcino-embryonic antigen (CEA), SCC and Cyfra 
21-1. The study found that the salivary concentration of all these markers was increased in 
cancer patients than in normal controls. However concentration of SCC, CA19-9 and CEA 
showed statistically significant differences while the others did not (Nagler et al., 2006). 
Contucci et al., (2005) analyzed statherin levels in oral pre-cancer and cancer and found 
decreased statherin levels compared to healthy controls. Statherin possess high affinity for 
calcium and phosphorus minerals and provides protective effect which can delay and 
decrease the level of proliferation induced by carcinogen and reduction of this protective 
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effect is associated with an increased penetration of environmental carcinogens through the 
mucosal surface. 
Cyfra 21-1 is a soluble fragment of cytokeratin 19, which is a component of cytoskeletal 
protein with a molecular weight of 40kDa. Cleavage of CK19 through caspases 3 activity 
releases cyfra21-1 into the extracellular space. A study evaluated salivary cyfra21-1 levels in 
OSCC using ELISA kits and compared with normal and found significantly increased levels 
in OSCC group. The study also found that the pre-operative saliva Cyfra 21-1 levels were 
significantly higher in patients suffering from tumor recurrence than in patients without 
recurrence. The study highlights the usefulness of Cyfra 21-1 for tumor detection and 
predicting recurrence. It has been postulated that increased Cyfra 21-1 could be due to 
increased CK19 expression in tissues (Ping et al., 2007). 
Salivary soluble CD44 levels were evaluated in head and neck squamous cell carcinoma 
compared with controls (Franzmann et al., 2005). CD44 are adhesion molecules expressed 
on normal T-lymphocytes and is used by these cells to migrate to selective sites in the 
lymphoid tissue. Such migration is accompanied by binding of CD44 to hyaluronate on high 
endothelial venules and overexpression of this molecule may favor metastatic spread 
(Kumar et al., 2005). These isoforms arise from alterative splicing of a variable exon present 
in CD44 mRNA. Franzmann et al., (2005) performed the study using ELISA and western 
blotting and demonstrated increased value in head and neck squamous cell carcinoma than 
in controls, suggesting their usage in early detection of cancer. 
P53 gene is lovated on chromosome 17p and functions as a critical gatekeeper against 
development of cancer. They also function as critical modulator of the cellular response to 
exogenous and endogenous stress. The main functional activity of p53 protein is cell cycle 
arrest and initiation of apoptosis in response to DNA damage. In a study by Liao et al., 
(2000), mutation of p53 was observed in DNA extracted from saliva of OSCC patients 
suggesting a potential use as biomarker for oral cancer detection. The study concentrated on 
p53 exon 4 codon 63 mutations which was significantly higher. 
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan made of repeating disaccharide 
units, D-glucoronic acid and N-acetyl- D- glucosamine responsible for regulation of cell 
adhesion, migration and proliferation. They support metastasis by promoting tumor cell 
migration offering protection against immune surveillance and causing a partial loss of 
contact mediated inhibition of cell growth and migration. Hyaluronidase is an 
endoglycosidase that degrades HA into small angiogenic HA fragments. HAase is shown to 
alter the expression of CD44 isoforms which may be involved in tumor progression 
(Franznmann et al., 2003). Franznmann et al., (2003) in their study showed statistically 
significant rise in HA and HAase in OSCC patients than normal controls suggesting their 
role as potential marker for diagnosis and prognosis of head and neck SCC.  
Balicki et al., (2005) estimated EGF levels in saliva of oral cancer and compared with controls 
and found significantly decreased EGF levels in OSCC patients. It was suggested that the 
impaired ability to heal oral mucosal damage in neoplastic diseases may be related to low 
EGF concentration in saliva. The weaker mitogenic effect due to decreased EGF 
concentration reduces the reconstructive potential of oral mucus membrane epithelium in 
patients suffering from oral cavity cancer. 
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Analysis of interleukin 6 & 8 in OSCC patients revealed significantly higher values than in 
normal controls. Increased interleukin 6 has been shown to promote immune 
unresponsiveness and induction of wasting, cachexia and hypercalcemia. Interleukin 8 plays 
a role in stimulation of angiogenesis, proliferation and chemotaxis of granulocytes and 
mecrophages which are prominent constituents in the stroma of OSCC (St. John et al., 2004). 
Estimation of salivary sialic acid as a tumor marker was considered as aberrant 
glycosylation are universal features of cancer. A study performed to evaluate salivary sialic 
acid, total protein and total sugar in OSCC patients found significantly increased levels in 
OSCC patients than in healthy controls (Sanjay et al., 2008, Debensteen et al., 1991). Another 
protein evaluated was statherin and results have shown increased levels in OSCC group 
than in normal controls (Contucci et al., 2005). 
Free radical generation result in production of reactive oxygen species which at high levels 
are known to cause DNA based alteration, strand breaks, damaged tumor suppressor genes 
and enhanced expression of proto-oncogenes. Numerous anti-oxidants exist in the body that 
protects from the damaging effects of reactive oxygen species and reactive nitrogen species. 
Any imbalance in oxidant-antioxidant balance contributes to cancer development and hence 
determination of salivary oxidant and antioxidant levels may be helpful in early detection, 
treatment planning and prevention of tumor recurrence. 
Salivary nitrites are produced by tobacco and fungal organisms which are of special 
importance in carcinogenesis as they form nitrosamines. Studies have shown that salivary 
DNA and proteins to be profoundly oxidized with increased salivary reactive nitrogen 
species while all salivary antioxidants were significantly reduced (Bahar et al., 2007). Studies 
by Rai et al., (2008) showed significantly elevated levels of malondialdehyde in pre-cancer 
and cancer.  
In addition to the use of saliva in oral cancer detection, evidence support the usage of saliva 
in diagnosis of cancer from other sites such owing to the fact that many markers which are 
identified in other cancers can be isolated from saliva. Markers such as C-erbB2 and CA15-3 
for breast cancer, CA125 for ovarian cancer, kallikrein and epidermal growth factor for 
breast cancer have been evaluated and found to be very useful in the detection of distant 
tumors (Streckfus & Bigler, 2005)  
4.2 Genomic markers 
Tumor specific genomic markers consisting of DNA and RNA markers can be identified in 
saliva for detection of oral cancer considering that the initiation and progression of 
malignant tumors is driven by the accumulation of specific genetic alterations. DNA shows 
tumor specific characteristics such as somatic mutations in tumor suppressor genes and p53, 
microsatellite alteration, abnormal promoter methylation, mitochondrial DNA mutations 
and presence of tumor related viral DNA. In addition transcript levels of mRNA, microRNA 
levels are also considered as diagnostic markers for oral cancer. 
Microsatellite DNA consist of tandem repeats of one to six nucleotides scattered throughout 
the genome. DNA microsatellites are highly polymorphic and vary between every 
individual. These microsatellite sequences are fixed for an individual and same in every 
tissue. Any error in mismatch repair, creates microsatellite instability which has been 
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successfully used as molecular markers for analysis of tumorigenesis in head and neck 
cancer (Kumar et al, 2004). Loss of heterozygosity (LOH) is a term used to describe a 
condition where the cell becomes homozygous to a mutant allele resulting in cancer 
development. LOH can occur through mechanisms such as loss of a chromosome through 
mitotic non-disjunction, deletion on the chromosome carrying the corresponding allele and 
cross over between two homologous genes leading to homozygosity for the mutant allele 
(Muelker & Young, 2004). 
Studies using microsatellite markers from different chromosomal arms in head and neck 
SCC have shown alterations at certain regions on chromosome 3p, 9p, 17p & 18q to be 
associated with development of tumors (El- Naggar et al, 2001). El- Naggar et al., (2001) 
evaluated salivary samples to analyze DNA and showed highest incidence of microsatellite 
LOH of chromosome 9p, 3p &17p. 
Methylation is the main epigenetic modification in humans and changes in methylation 
pattern plays a main role in tumorigenesis. Epigenesis is the alteration of gene activity 
without change in their structure (Kumar et al., 2004). Certain tumor suppressor genes are 
inactivated by hypermethylation of promoter sequences without a change in DNA base 
sequence resulting in loss of expression.  
p16INK4A also known as CDKN2A is a cyclin dependent kinase inhibitor which is critical in 
cyclin D-Rb pathway for maintaining Rb protein in its active, non-phosphorylated state. It 
blocks CDK4 binding to cyclin thus helping in cell cycle regulation. Any mutation of 
p16INK4A occurring in tumors result in inability to block cyclin D-CDK4 activity and 
preventing Rb phosphorylation during cell cycle. O-methylguanine-DNA-methyltransferase 
(MGMT) is DNA repair gene for guanosine methyl adduct; death associated protein kinase 
(DAP-K) is a novel serine/ threonine kinase whose expression is required for interferon 
induced apoptosis which functions as a potential metastasis inhibitor (Rosas et al., 2001).The 
study by Rosas et al., (2001) determined the promoter hypermethylation of the above three 
markers in saliva of patients with head and neck SCC and normal controls and found that 
56% of the cases exhibited promoter hypermethylation in atleast one of the genes. Among 
the cases, 47% exhibited hypermethylation at p16, 33% at DAP-K and 23% at MGMT. The 
authors suggested that these alterations can be used for early detection of cancer and also 
for detection of natural progression from neoplasia to cancer in at risk population. 
Righini et al., (2007) tried to define a gene methylation profile in head and neck SCC tumors 
and saliva for diagnosis and follow up by analyzing eleven genes. They found that six 
methylated genes were most frequently found which included tissue inhibitors of 
metalloproteinase (TIMP 40%), ECAD (36%), MGMT (29%), p16(29%), DAPK (27%) & 
RASSF1A (20%). It was suggested that aberrant methylation of these 6 genes in exfoliated 
malignant cells of the saliva reflects tumor status. TIMP3 encodes for metalloproteinase 
inhibitor that suppresses tumor growth, angiogenesis, invasion and metastasis.  
Detection of telomerase activity in saliva of OSCC was performed by Zhong et al., (2005) 
and they detected telomerase positivity in 75% of cases suggesting that telomerase detection 
could be used as assistant marker in OSCC. Telomerase is a ribonucleoprotein aid to 
elongate repeat sequence at the end of the chromosomes. Reactivation of telomerase is 
considered to be a pre-requisite for development of malignant tumor cells from somatic 
cells. 
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Adenosine deaminase (ADA) and 5’- nucleotidase (5’-NT) are important enzymes 
participating in purine and DNA metabolisms. Defect in ADA results in intracellular 
accumulation of adenosine and deoxyadenosine which are toxic to living cells. 
Deoxyadenosine causes dATP accumulation which is strong inhibitor of ribonucleotide 
reductase and cause some aberrations in DNA synthesis. They also interfere with critical 
methylation dependent process such as synthesis, maturation or function of DNA. 
Saracoglu et al., (2005) found decreased ADA in oral cancer patients and suggested that it 
may be a compensatory mechanism against rapid purine and DNA metabolism in cancer 
cells. Decreased ADA activities cause higher dATP and AMP concentration in the cell, 
thereby lowering dATP and dAMP ratio and leading to decreased energy production. This 
may be a limiting factor against rapid proliferation of cancer cells. 
In a study conducted by Yang et al., (2004), microarray analysis of salivary transcriptome 
showed that there are 1679 genes exhibiting different expression levels between cancer 
patients and controls. Of these, seventeen cancer related biomarkers showed significant 
elevation (3.5 fold) and quantitative PCR was performed to validate these findings. Nine 
markers were then selected based on their reported cancer association (DUSP 1, GADD45B, 
H3F3A, IL1B, IL8, OAZ1, RGS2, S100P & SAT). The results confirmed that seven of these 
nine markers showed significant elevation in saliva of OSCC patients. The validated seven 
genes could be classified in three ranks by the magnitude of increase into highly 
upregulated mRNA (IL-8), moderately upregulated mRNA (H3F3A, IL1B, S100P) and low 
upregulated mRNA (DUSP1, OAZ1 &SAT).  
 
Gene 
symbol 
Gene name Functions 
DUSP-1 
Dual specificity 
phosphatase 1 
Protein modification, signal transduction, 
oxidative stress 
H3F3A H3 histone, family 3A DNA binding activity 
IL1 β Interleukin-1β Signal transduction, proliferation, inflammation, 
apoptosis 
IL 8 Interleukin-8 
Angiogenesis, replication, Ca++ mediated 
signaling pathway, cell adhesion, chemotaxis, cell 
cycle arrest, immune response 
OAZ-1 
Ornithine 
decarboxylase 
antizyme-1 
Polyamine synthesis 
S-100P 
S-100 Ca++ binding 
protein P 
Protein binding, Ca++ ion binding 
SAT 
Spermidine / Spermine 
N1-acetyl transferase 
Enzyme, transferase activity. 
Table 2. Salivary mRNA showing significant changes in oral cancer with their functions. 
MicroRNAs (miRNA) are a group of small RNAs, 19-25 nucleotides in length, involved in 
the regulation of development and cell differentiation, proliferation and survival. They exert 
their effects by two mechanisms; mRNA degradation and inhibition of translation. A single 
miRNA is capable of regulating the translation of a multitude of genes by targeting specific 
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regions in their mRNA transcript. As a single miRNA can regulate hundreds of genes and 
may act as a master regulator of processes; select subsets of miRNAs can be used as 
biomarkers of physiological and pathological states (Micheal et al., 2010). 
Analysis of miRNA from saliva of OSCC patients was performed by Park et al., (2009). Of 
the total number of miRNA analyzed, four potential miRNA were identified as being 
present in statistically significant levels between the two groups. These included miR-200a, 
miR-125a, miR-142-3p & miR-93. Further analysis of these miRNA in a separate set of OSCC 
and normal patients suggested that miR-200a and miR-125a were present in significantly 
lower levels in OSCC than in healthy controls. These findings suggested that the detection of 
miRNA in saliva can be used as a non-invasive and rapid diagnostic tool for oral cancer 
detection. These were considered as the third diagnostic alphabet in saliva (Park et al., 2009).  
4.3 Salivary microbiota 
A multitude of microorganisms thrive in the oral cavity interacting with each other and at 
times causing clinical diseases. Oral cavity plays host to a wide array of microorganisms 
inclusive of variety of bacteria, viruses and fungi. This natural microflora is essential for the 
normal development of host physiology and contributes to host defenses by excluding 
exogenous microorganisms. Certain alterations in diet, medications, habits and host 
immune status may lead to overgrowth of minor components of oral microflora which can 
predispose the site to disease. Organisms such as candida act as opportunistic pathogens 
contributing to various oral diseases. The role of bacteria in oral cancer is currently being 
investigated to determine if the role is a causal or it is a co-incidental finding. 
Kang et al., (2009) evaluated the salivary levels of group of organisms (cariogenic, 
periodontopathic and fungal) and demonstrated significant increase in the levels of P. 
Gingivalis, T. Forsythia & C. albicans in cancer group than in normal controls. The study also 
found that the prevalence of S. sobrinus in healthy group was significantly lower than in 
healthy head and neck tumors.  
Mager et al., (2005) determined salivary counts of forty common oral bacteria in OSCC and 
normal controls using DNA hybridization techniques. They found significantly elevated 
levels of P. gingivalis, P. melaninogenica & S.mitis in saliva of OSCC patients thereby 
suggesting the role of salivary microbiota as a diagnostic indicator in OSCC.  
Candida species are normal commensals of the oral cavity and evidence suggest their 
involvement in oral cancer development primarily through nitrosation of nitrosobenzene 
compounds (Krogh, 1990). Studies have found increased candidal carriage in salivary 
samples of OSCC group than in normal controls (Kang et al., 2009). This indicates that the 
salivary analysis of candida species might be useful as diagnostic and prognostic indicator 
of oral pre-cancer and cancer.  
5. Conclusion 
Saliva has been considered as the mirror image of blood for a long time and its various 
components acts as a mirror of body’s health. Since the ancient times, saliva has been used 
for detection of various diseases ranging from autoimmune diseases to infections and cancer 
among others. The identification of many new components along with the introduction of 
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newer technologies has led researchers to believe that saliva could be used as an attractive 
tool. Salivary analysis is advantageous due to the easy and non-invasive method of 
collection, safety and the possibility of repeated collection without discomfort to the patient. 
However, saliva analysis was not considered to be effective owing to the inability to isolate 
minor components as a result of technological barriers. Emerging technologies with high 
sensitivity and specificity developed in the recent past have overcome these problems 
giving a new dimension to the use of saliva as a diagnostic tool.  
Saliva is normally composed of many organic and inorganic constituents and identification 
of these proteins in disease states were considered useful from a diagnostic perspective. 
Salivary proteins, nucleic acids and microbiota have been studied in oral cancer with an aim 
to identify specific components that could serve as a useful marker for cancer detection as 
well as treatment planning. Advances like proteomics which is used to detect a panel of 
proteins, transcriptomics for DNA and RNA and genomics for determination of genetic 
damage are helpful for characterization of disease states. With point of care diagnostics 
being the requirement of the day salivary analysis could become a routine procedure for 
cancer detection. 
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